We describe the identification and purification of a receptor for calcitonin-gene-related peptide (CGRP) from human term placenta, using lectin and P-CGRP -Affigel affinity chromatography. The membrane-bound receptor has an estimated M , of 240000, as determined by cross-linking 1251-labelled a-CGRP (1251-a-CGRP) using discuccinimidyl suberate and SDS/polyacrylamide gel electrophoresis, or of 263 000, as judged by sucrose gradient centrifugation of the soluble partially purified native receptor preparation. Cross-linking studies with disuccinimidyl suberate and N-hydroxysuccinimidyl-4-azidobenzoate using membrane-solubilised, partially purified and CGRP-affinity-purified preparations, show a number of '251-or-CGRP binding subunit(s) of M , 62000 -68000. Silver staining of the purified CGRP receptor preparation showed two distinct doublets in this plus a number of minor doublets of lower M,. The receptor binds human fl-CGRP with greater affinity than a-CGRP, and showed little affinity for human calcitonin. Adsorption isotherms and Scatchard analysis of lZ51-a-CGRP binding to the membrane-bound or soluble purified receptor are consistent, under the conditions used, with a single binding site of high affinity. Molecular cloning at present in progress should define the amino acid sequence and subunit composition of the human placental CGRP receptor, since at present the observed heterogeneity of CGRP-binding proteins may be interpreted in a number of ways, for instance: receptor heterogeneity, variable glycosylation of one of two subunits, or limited proteolysis of a single subunit during purification.Studies on the structure and expression of the rat and human calcitonin genes have demonstrated the generation by RNA processing of alternative mRNA species from a single gene in a tissue-specific manner [l -41. The mRNA species produced encode polyproteins cleaved by post-translational events to yield either calcitonin, the major gene product in the thyroid, or a predicted 37-amino-acid amidated peptide, the calcitonin-gene-related peptide (a-CGRP). A second gene encoding a similar peptide (P-CGRP) has also been identified in rat and man [2 -61. Immunohistochemical studies using antisera raised against synthetic CGRP peptides have revealed the presence of CGRP-like material in discrete areas of the brain, and in extensive networks of sensory nerves, in particular nerves supplying the vasculature [7 -111. Elevated human plasma CGRP levels have also been documented in medullary thyroid carcinoma and lung carcinoma [3,4,12